However, when patients stopped taking Tesamorelin, the fat reduction benefits were quickly reversed, suggesting that continued use is necessary to maintain results
8.9 Race/Ethnicity No consistent differences in the efficacy and safety of SYMLIN have been observed among patients of differing race/ethnicity in SYMLIN clinical trials (n=4257 for Caucasian, n=229 for black, n=337 for Hispanic or Latino, and n=61 for Asian and one or more races) although the smaller sample sizes for non-Caucasians, particularly Asians, limit conclusions
Phase 2 data is promising but not a substitute for the full Phase 3 safety and efficacy review
It stays in the body longer, allowing you to take it just once a week
Benefits: Supports effective weight reduction and appetite regulation, stabilizes blood glucose levels, promotes cardiovascular health, reduces chronic low-grade inflammation, and helps alleviate metabolism-related fatigue